Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bone Marrow Neoplasm”

3,515 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,515 results

Testing effectiveness (Phase 2)Study completedNCT00339196
What this trial is testing

5-azacytidine Valproic Acid and ATRA in AML and High Risk MDS

Who this might be right for
Acute Myelogenous Leukaemia (AML)Myelodysplastic Syndrome (MDS)
Assistance Publique - Hôpitaux de Paris 25
Testing effectiveness (Phase 2)Ended earlyNCT00005986
What this trial is testing

Chemotherapy, Filgrastim and Peripheral Stem Cell Transplantation in Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Masonic Cancer Center, University of Minnesota
Post-approval studies (Phase 4)UnknownNCT05353205
What this trial is testing

The Efficacy and Safety of Flumatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.

Who this might be right for
CML, Chronic Phase
Jiangsu Hansoh Pharmaceutical Co., Ltd. 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07394153
What this trial is testing

Pacritinib For Bone Marrow Fibrosis In Patients With Myelofibrosis Who Have Thrombocytopenia

Who this might be right for
Myelofibrosis，MF
Grupo Español de Enfermedades Mieloproliferativas Crónicas PH Negativas 30
Very early researchUnknownNCT03228303
What this trial is testing

Nilotinib Versus Imatinib in Treatment of Patients With Newly Diagnosed Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia
Assiut University 100
Testing effectiveness (Phase 2)Looking for participantsNCT06046313
What this trial is testing

Prolonged Ultra Low-dose Decitabine Plus Venetoclax for Primary Diagnosed Elderly AMLK/MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
First Affiliated Hospital of Zhejiang University 120
Large-scale testing (Phase 3)Ended earlyNCT01645124
What this trial is testing

Large-scale Trial Testing the Intensity of CYTOreductive Therapy in Polycythemia Vera (PV)

Who this might be right for
Polycythemia Vera
Consorzio Mario Negri Sud 365
Testing effectiveness (Phase 2)Study completedNCT00262886
What this trial is testing

Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
University of Rochester 35
Not applicableStudy completedNCT01146223
What this trial is testing

Biomarkers in Bone Marrow Samples From Patients With Acute Promyelocytic Leukemia

Who this might be right for
Adult Acute Myeloid LeukemiaAdult Acute Myeloid Leukemia With t(15;17)(q22;q12)Adult Acute Promyelocytic Leukemia (M3)+1 more
Children's Oncology Group 10
Not applicableStudy completedNCT01860456
What this trial is testing

TyrosIne Kinase Inhibitors in Chronic Myeloid Leukemia: Efficacy and Tolerability. The TIKlet Study

Who this might be right for
Chronic Myeloid Leukemia
University of Pisa 412
Testing effectiveness (Phase 2)Ended earlyNCT01038856
What this trial is testing

Trial of Erlotinib in Patients With JAK-2 V617F Positive Polycythemia Vera

Who this might be right for
Polycythemia Vera
University of Oklahoma 5
Early research (Phase 1)Study completedNCT00255710
What this trial is testing

Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 60
Testing effectiveness (Phase 2)Study completedNCT01856283
What this trial is testing

Nilotinib 300 mg BID in Newly Diagnosed CP-CML Patients to Verify Disappearance of CD34+/Lin-Ph+ Cells

Who this might be right for
Leukemia, Myeloid, Chronic-Phase
Niguarda Hospital 87
Not applicableUnknownNCT00899327
What this trial is testing

Biomarkers in Patients at Risk of Developing Myelodysplastic Syndrome or Other Disorders and in Healthy Participants

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Oxford University Hospitals NHS Trust 200
Testing effectiveness (Phase 2)Study completedNCT00003270
What this trial is testing

Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Roswell Park Cancer Institute 20
Early research (Phase 1)Ended earlyNCT00058773
What this trial is testing

Giving Gene Marked EBV Specific T-Cells to Patients Receiving a BMT for Relapsed EBV-Positive Hodgkin Disease

Who this might be right for
Hodgkin DiseaseNon-Hodgkins Lymphoma
Baylor College of Medicine 5
Not applicableEnded earlyNCT00514722
What this trial is testing

Pilot Study of Umbilical Cord Blood Transplantation in Adult Patient With Advanced Hematopoietic Malignancies

Who this might be right for
Acute Myeloid LeukemiaMyelodysplasiaAcute Lymphoblastic Leukemia+7 more
University of California, San Francisco 4
Not applicableUnknownNCT00445822
What this trial is testing

Registration of Children With CML and Treatment With Imatinib

Who this might be right for
Myeloid Leukemia, Chronic
Technische Universität Dresden 150
Not applicableNo Longer AvailableNCT00413270
What this trial is testing

Oral Nilotinib in Adults With Chronic Myeloid Leukemia (CML) in Blast Crisis Who Are Imatinib Resistant or Intolerant

Who this might be right for
Chronic Myelogenous Leukemia
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Looking for participantsNCT05211570
What this trial is testing

AB8939 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia RefractoryAcute Myeloid Leukemia, in RelapseMyelodysplastic Syndrome Acute Myeloid Leukemia
AB Science 78
Load More Results